Patient decision aids for cancer treatment

Are there any alternatives?

Authors

  • Gillian Spiegle BSc,

    1. University of Toronto, Toronto, Ontario, Canada
    2. Division of General Surgery, Mount Sinai Hospital and Samuel Lunenfeld Research Institute, Toronto, Ontario, Canada
    Search for more papers by this author
  • Eisar Al-Sukhni MD,

    1. University of Toronto, Toronto, Ontario, Canada
    2. Division of General Surgery, Mount Sinai Hospital and Samuel Lunenfeld Research Institute, Toronto, Ontario, Canada
    3. Zane Cohen Centre for Digestive Diseases, Toronto, Ontario, Canada
    Search for more papers by this author
  • Selina Schmocker BSc,

    1. Division of General Surgery, Mount Sinai Hospital and Samuel Lunenfeld Research Institute, Toronto, Ontario, Canada
    2. Zane Cohen Centre for Digestive Diseases, Toronto, Ontario, Canada
    Search for more papers by this author
  • Anna R. Gagliardi PhD,

    1. University of Toronto, Toronto, Ontario, Canada
    2. Toronto General Hospital and Toronto General Research Institute, Toronto, Ontario, Canada
    3. Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
    Search for more papers by this author
  • J. Charles Victor MSc,

    1. University of Toronto, Toronto, Ontario, Canada
    2. Institute of Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada
    3. Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
    Search for more papers by this author
  • Nancy N. Baxter MD, PhD,

    1. University of Toronto, Toronto, Ontario, Canada
    2. Institute of Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada
    3. Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
    4. Department of Surgery and Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada
    Search for more papers by this author
  • Erin D. Kennedy MD, PhD

    Corresponding author
    1. University of Toronto, Toronto, Ontario, Canada
    2. Division of General Surgery, Mount Sinai Hospital and Samuel Lunenfeld Research Institute, Toronto, Ontario, Canada
    3. Zane Cohen Centre for Digestive Diseases, Toronto, Ontario, Canada
    4. Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
    5. Department of Surgical Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada
    • Division of General Surgery, Mount Sinai Hospital, 600 University Avenue, Suite 455, M5G 1X5, Toronto, Canada

    Search for more papers by this author
    • Fax: (416) 586-5932


Abstract

BACKGROUND:

Although patient decision aids (pDAs) are effective, widespread use of pDAs for cancer treatment has not been achieved. The objectives of this study were to perform a systematic review to identify alternate types of decision support interventions (DSIs) for cancer treatment and a meta-analysis to compare the effectiveness of these DSIs to pDAs.

METHODS:

The inclusion criteria for the study were: 1) all published studies using a randomized, controlled trial design, and 2) DSIs involving treatment decision-making for breast, prostate, colorectal, and/or lung cancer. For this analysis, DSIs were classified as pDAs if: 1) one reported outcome measure mapped onto the International Patient Decision Aids Standards Collaboration effectiveness criterion, and 2) the DSI was evaluated relative to standard consultation. Random effects models were used to compare the effectiveness of pDAs relative to other identified DSIs for reported outcomes.

RESULTS:

A total of 71 studies were reviewed, and 24 met the inclusion criteria. Overall, there were no significant differences in knowledge, satisfaction, anxiety, or decisional conflict scores between pDAs and other DSIs.

CONCLUSIONS:

This study showed that the effectiveness of other DSIs, including question prompt lists and audiorecording of the consultation, is similar to pDAs. This is important because it may be that these less complex DSIs may be all that is necessary to achieve similar outcomes as pDAs for cancer treatment. Cancer 2013. © 2012 American Cancer Society.

Ancillary